BiotechTube
Home/Oxurion/Charles Paris de Bollardière
CP

Charles Paris de Bollardière

Chairman Of The Board

Oxurion

Therapeutic Areas

OphthalmologyRetinal Diseases

Oxurion Pipeline

DrugIndicationPhase
Undisclosed Next-Gen TherapiesGeographic Atrophy (GA) / Age-related Macular Degeneration (AMD)Unspecified

Leadership Team at Oxurion

PG
Pascal Ghoson
CEO/CFO
JH
James Hartmann
Independent Non-Executive Director
NS
Nelly Souleymane
Independent Non-Executive Director
View full Oxurion profile